Terms: = Liver cancer AND SMO, Q99835, 6608, ENSG00000128602, SMOH, Gx
65 results:
1. Gut Bacteria Provide Genetic and Molecular Reporter Systems to Identify Specific Diseases.
Dicks LMT
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674014
[TBL] [Abstract] [Full Text] [Related]
2. Performance analysis of data resampling on class imbalance and classification techniques on multi-omics data for cancer classification.
Yang Y; Mirzaei G
PLoS One; 2024; 19(2):e0293607. PubMed ID: 38422094
[TBL] [Abstract] [Full Text] [Related]
3. Pathway-driven analysis of synthetic lethal interactions in cancer using perturbation screens.
Karimpour M; Totonchi M; Behmanesh M; Montazeri H
Life Sci Alliance; 2024 Jan; 7(1):. PubMed ID: 37863651
[TBL] [Abstract] [Full Text] [Related]
4. liver Imaging Reporting and Data System version 2018 category 5 for diagnosing hepatocellular carcinoma: an updated meta-analysis.
Lee S; Kim YY; Shin J; Roh YH; Choi JY; Chernyak V; Sirlin CB
Eur Radiol; 2024 Mar; 34(3):1502-1514. PubMed ID: 37656177
[TBL] [Abstract] [Full Text] [Related]
5. Inter-observer agreement and accuracy of LI-RADS v2018 for differentiating tumor in vein from bland thrombus using gadoxetic acid-enhanced magnetic resonance imaging.
Ichikawa S; Sirlin CB; Cunha GM; Wolfson T; Fowler KJ; Morisaka H; Onohara K; Shimizu T; Omiya Y; Sugiyama H; Okumura A; Onishi H
Abdom Radiol (NY); 2023 Aug; 48(8):2557-2569. PubMed ID: 37246973
[TBL] [Abstract] [Full Text] [Related]
6. Drug Repurposing Flubendazole to Suppress Tumorigenicity via PCSK9-dependent Inhibition and Potentiate Lenvatinib Therapy for Hepatocellular Carcinoma.
Jin W; Yu J; Su Y; Lin H; Liu T; Chen J; Ge C; Zhao F; Geng Q; Mao L; Jiang S; Cui Y; Chen T; Jiang G; Li J; Miao C; Xiao X; Li H
Int J Biol Sci; 2023; 19(7):2270-2288. PubMed ID: 37151886
[TBL] [Abstract] [Full Text] [Related]
7. The pharmacokinetics and safety of lidocaine in liver cancer patients undergoing hepatic resection.
He C; Jin Y; Zhang Y; Zhang M; Di X; Fu L; Qi X; Liu R; Zheng L; Wang Z; Li J; Tu F
Eur J Clin Pharmacol; 2023 Jun; 79(6):829-839. PubMed ID: 37074366
[TBL] [Abstract] [Full Text] [Related]
8. Comparison of anti-tumor activities and underlying mechanisms of glucuronomannan oligosaccharides and its sulfated derivatives on the hepatocarcinoma Huh7.5 cells.
He X; Chen F; Lu C; Wang S; Mao G; Jin W; Zhong W
Biochem Biophys Res Commun; 2023 Apr; 652():103-111. PubMed ID: 36841097
[TBL] [Abstract] [Full Text] [Related]
9. Combined Inhibition of smoothened and the DNA Damage Checkpoint WEE1 Exerts Antitumor Activity in Cholangiocarcinoma.
Anichini G; Raggi C; Pastore M; Carrassa L; Maresca L; Crivaro E; Lottini T; Duwe L; Andersen JB; Tofani L; Di Tommaso L; Banales JM; Arcangeli A; Marra F; Stecca B
Mol Cancer Ther; 2023 Mar; 22(3):343-356. PubMed ID: 36807728
[TBL] [Abstract] [Full Text] [Related]
10. Percentages of Hepatocellular Carcinoma in LI-RADS Categories with CT and MRI: A Systematic Review and Meta-Analysis.
Lee S; Kim YY; Shin J; Son WJ; Roh YH; Choi JY; Sirlin CB; Chernyak V
Radiology; 2023 Apr; 307(1):e220646. PubMed ID: 36625748
[TBL] [Abstract] [Full Text] [Related]
11. Propofol Inhibits Biological Function of Hepatocellular Carcinoma Cells through LINC00475-Mediated Sonic Hedgehog Pathway.
Wu J; Zhou F; Lai S; Wang W; Wu T; Liu Y; Yang L
Pharmacology; 2023; 108(2):127-137. PubMed ID: 36516819
[TBL] [Abstract] [Full Text] [Related]
12. Simultaneous determination of lidocaine and its active metabolites in plasma by UPLC-MS/MS and application to a clinical pharmacokinetic study in liver cancer patients with laparoscopic hepatectomy.
Jin Y; He C; Di X; Fu L; Qi X; Liu R; Zheng L; Wang Y; Wang Z; Tu F
J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Sep; 1207():123362. PubMed ID: 35839626
[TBL] [Abstract] [Full Text] [Related]
13. Epigenetic aberrations of gene expression in a rat model of hepatocellular carcinoma.
Boycott C; Beetch M; Yang T; Lubecka K; Ma Y; Zhang J; Kurzava Kendall L; Ullmer M; Ramsey BS; Torregrosa-Allen S; Elzey BD; Cox A; Lanman NA; Hui A; Villanueva N; de Conti A; Huan T; Pogribny I; Stefanska B
Epigenetics; 2022 Nov; 17(11):1513-1534. PubMed ID: 35502615
[TBL] [Abstract] [Full Text] [Related]
14. Metformin exerts anti-tumor effects via Sonic hedgehog signaling pathway by targeting AMPK in HepG2 cells.
Hu A; Hu Z; Ye J; Liu Y; Lai Z; Zhang M; Ji W; Huang L; Zou H; Chen B; Zhong J
Biochem Cell Biol; 2022 Apr; 100(2):142-151. PubMed ID: 34990285
[TBL] [Abstract] [Full Text] [Related]
15. c-Myc-driven Hepatocarcinogenesis.
Moon H; Park H; Ro SW
Anticancer Res; 2021 Oct; 41(10):4937-4946. PubMed ID: 34593441
[TBL] [Abstract] [Full Text] [Related]
16. Isolated cancer stem cells from human liver cancer: morphological and functional characteristics in primary culture.
Hu M; Li M; Huang H; Lu C
Clin Transl Oncol; 2022 Jan; 24(1):48-56. PubMed ID: 34169442
[TBL] [Abstract] [Full Text] [Related]
17. MIRLET7BHG promotes hepatocellular carcinoma progression by activating hepatic stellate cells through exosomal smo to trigger Hedgehog pathway.
Xia Y; Zhen L; Li H; Wang S; Chen S; Wang C; Yang X
Cell Death Dis; 2021 Mar; 12(4):326. PubMed ID: 33771969
[TBL] [Abstract] [Full Text] [Related]
18. Silencing of long non‑coding RNA NEAT1 inhibits hepatocellular carcinoma progression by downregulating smo by sponging microRNA‑503.
Sun C; Xiao T; Xiao Y; Li Y
Mol Med Rep; 2021 Mar; 23(3):. PubMed ID: 33398379
[TBL] [Abstract] [Full Text] [Related]
19. The Role of smoothened in cancer.
Jeng KS; Sheen IS; Leu CM; Tseng PH; Chang CF
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32962123
[TBL] [Abstract] [Full Text] [Related]
20. Combined inhibition of JAK2-STAT3 and smo-GLI1/tGLI1 pathways suppresses breast cancer stem cells, tumor growth, and metastasis.
Doheny D; Sirkisoon S; Carpenter RL; Aguayo NR; Regua AT; Anguelov M; Manore SG; Arrigo A; Jalboush SA; Wong GL; Yu Y; Wagner CJ; Chan M; Ruiz J; Thomas A; Strowd R; Lin J; Lo HW
Oncogene; 2020 Oct; 39(42):6589-6605. PubMed ID: 32929154
[TBL] [Abstract] [Full Text] [Related]
[Next]
